TARO PHARMACEUTICALS CANADA
Jim Mihail is an experienced professional in the pharmaceutical industry with a focus on commercial operations and marketing. Currently serving as the Director of Commercial Operations at Taro Pharmaceuticals Canada since January 2017, Jim has previously held multiple director-level roles in marketing at Actavis Pharma Limited (now Allergan), Cobalt Pharmaceuticals, and Actavis plc between November 2010 and September 2016. Additionally, Jim served as Associate Director of Product Strategies at ratiopharm from January 2005 to September 2010, demonstrating a strong background in market supply and strategic planning within the sector.
This person is not in any teams
This person is not in any offices
TARO PHARMACEUTICALS CANADA
We are a global, research-driven, specialty pharmaceutical company. Established in 1950, Taro develops, manufactures and markets affordable prescription and over-the counter medications. With support from our parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company we are a powerful global presence. Our world class production facilities in Brampton, Ontario and nearly 600 Canadian employees give Taro Canada a uniquely Canadian perspective. Our Canadian focus on dermatology makes us a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from our competitors. We specialize in generic prescription products, but also produce over the counter and brand name drugs. Our strong research program and niche strategy have positioned us as a central player in the specialty pharmaceutical sector.